Should the left main be covered entirely with drug-eluting stents in percutaneous intervention

Iñigo Lozano1, Pablo Avanzas, Cesar Moris

  • 1Department of Cardiology, Hospital Central Asturias, Celestino Villamil, Oviedo, 33006, Spain. imlml9@hotmail.com

Insights

Restenosis can occur after left main coronary artery stenting. A new lesion developed in the unstented segment after balloon crushing, highlighting the need for optimal stent coverage in complex left main interventions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) disease aims to prevent adverse cardiac events.
  • Drug-eluting stents (DES) have improved outcomes, but optimal stent length and coverage in the LMCA remain debated.
  • Restenosis in the LMCA can lead to severe outcomes, including sudden cardiac death.

Observation:

  • A patient underwent successful PCI of the distal LMCA using two DES and a balloon crushing technique.
  • The intervention involved covering a portion of the distal LMCA, leaving a segment unstented.
  • The patient presented three months later with a new in-stent restenosis (ISR) or neo-intimal hyperplasia at the crush site.

Findings:

  • A new lesion developed in the LMCA segment that was not covered by the stent but was subjected to balloon inflation.
  • This finding suggests that the balloon crushing site, even if unstented, may be susceptible to neointimal proliferation or restenosis.
  • The precise length and optimal coverage strategy for DES in the LMCA require further investigation.

Implications:

  • The case highlights potential risks associated with incomplete stent coverage and balloon crushing in LMCA interventions.
  • It underscores the importance of precise stent length selection and deployment to ensure adequate coverage of the entire diseased LMCA segment.
  • Further studies are needed to refine techniques and optimize stent selection for LMCA PCI to minimize restenosis risk.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...